Latest Period
Q1 2026
Security Snapshot
TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA) Institutional Ownership
CUSIP: 140755208
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$5.32
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CARA
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 0
- Total 13F value
- $0
- Share change
- -132
- Value change
- -$568
- Number of holders
- 0
- Shares outstanding
- 9,346,119
- SEC-reported price per share
- $5.32
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CARA - TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 140755208.
- 0 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 3 to 0 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $568 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 0 institutions filings for Q1 2026.
Security key
140755208
Latest holder period
Q1 2026
13F holders
0
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
CARA full holder history
Tvardi Therapeutics, Inc. SEC filings
Tvardi Therapeutics, Inc. company facts
Tvardi Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 140755208:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
CARA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sporos Bioventures LLC | 9% | $19,544,812 | 837,636 | Sporos Bioventures LLC | 15 Apr 2025 | |||
| Solas Tvardi Sidecar LLC | 8.1% | $4,050,047 | 761,287 | Solas Tvardi Sidecar LLC | 15 Apr 2025 | |||
| Tweardy David John | 7% | $3,470,757 | 652,398 | David J. Tweardy | 15 Apr 2025 | |||
| DePinho Ronald A | 6.7% | -20% | $24,413,770 | -$6,035,311 | 626,190 | -20% | Ronald A. DePinho | 30 Sep 2025 |
| Tweardy Samuel David | 3.4% | -67% | $7,365,343 | -$14,730,686 | 315,658 | -67% | Samuel D. Tweardy | 07 Jul 2025 |
As of 31 Mar 2026, 0 institutional investors reported holding 0 shares of TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA). This represents 0% of the company’s total 9,346,119 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q1 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$568 | $5.32 | 0 |
| 2025 Q4 | 132 | $568 | -$861,996 | $4.33 | 3 |
| 2025 Q3 | 22,165 | $862,745 | +$8,201 | $39.00 | 8 |
| 2025 Q2 | 21,929 | $511,606 | -$2,705,206 | $23.33 | 7 |
| 2025 Q1 | 633,363 | $3,211,465 | -$2,599,722 | $5.07 | 33 |
| 2024 Q4 | 1,075,203 | $6,580,102 | +$6,496,611 | $6.12 | 39 |
| 2024 Q3 | 250 | $77 | +$77 | $0.31 | 1 |